dismiss

Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
Advertisement

 

 

Rad Oncology Homepage

Four considerations before embarking on a carbon therapy center The next frontier in improving cancer care

Q & A with Scott Warwick, executive director of the National Association for Proton Therapy Find out what to expect at the year's biggest proton therapy industry event

New approach identifies lung cancer patients most likely to respond to chemotherapy Combines radiomics and CT image assessment

Aussies and Americans develop 3D models for assessing impacts of radiotherapy Test different levels and types of radiation

Law in Ontario prevents cremation of brachytherapy patients Experts call for eliminating the law, as it deters patients from lifesaving treatment

IBA tech plays first-time role in flash therapy demonstration Supports eventual integration of flash as clinical treatment

Access to proton therapy increasing for pediatric patients Young cancer patients have the most to gain from proton treatment

Public-private partnership replaces 50-year old radiotherapy equipment in Guatemala Upgrading to Varian Halcyon system

Hypofractionated radiotherapy no worse than conventional RT, says study No difference in progression and survival

Proton therapy market continues decline after 2015 high point: report By comparison, investment in 2018 dropped 62 percent

Personalized radiotherapy 'start of a new era' with aid of radiomics imaging

by John W. Mitchell , Senior Correspondent
A team of radiation oncologists at the Moffitt Cancer Center in Florida want to do for radiation oncology patients what chemotherapy patients have benefitted from for years: receive treatment that is individualized, based on genomic biomarkers.

"We want to bring individualized radiation treatment, based upon specific gene signatures, tumor type, and patient response, to improve outcome and reduce toxicity," Louis B. Harrison, M.D., chair of the Radiation Oncology Department at Moffitt, told HCB News. "The current paradigm is to treat every patient with the same cancer and the same stage with the same radiation program. To make this care individualized is truly an exciting development."

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



Radiation therapy is one of the most common treatments to fight cancer. About 500,000 people a year received such treatments, according to Moffitt data. Harrison said the individualized protocols are made possible by the radiosensitivity index (RSI), developed at Moffitt under the leadership of Javier Torres-Roca, M.D. Details of the RSI road map were just published by Harrison, Torres-Roca and another colleague, Jimmy Caudell, M.D., Ph. D., in the May issue of The Lancet Oncology.

The RSI is a mathematical algorithm validated in multiple different groups across tumor types. Harrison said that when the index is combined with the field of radiomics, mathematical modeling and adaptive response evaluation, including the use of MR and CT scans during radiation therapy, the case for individualized treatment is even more likely.

Current treatment is limited by the fact that there has not been biological data (biopsies and 2-D imaging, as opposed to 3-D modeling and the RSI) to guide adaptive changes for individualized radiation treatment.

Harrison said that Caudell and Torres-Roca would be initiating a clinical trial in oropharynx cancer at Moffitt later this year to test the RSI model in patients."

"This is a cancer that is highly curable, and we think we can accomplish good outcomes with lower doses of radiation," said Harrison. "Lower doses mean fewer side effects, and less cost, so personalized treatment offers a lot of benefit to the patient. This is the start of new era in radiation oncology."

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED